Jyothy Labs plans lower-crude products next year to protect margins

Jyothy Labs Limited expects to introduce products with lower crude dependency next year after management said unprecedented crude-price inflation affected profitability and an analyst characterised about 65% of its total cost base as crude-dependent. Management said the products under development are intended to have better margin profiles, but it gave no categories, revenue target or launch dates.

How exposed is Jyothy Labs to crude-linked costs?

Jyothy Labs has short-term exposure to crude-linked inputs, with an analyst stating that around 65% of total costs depend on crude. Management did not independently quantify that share in its response, but said the dependency exists and that the increase in crude prices had affected the profitability of the business.

The company’s stated response is new product development, or NPD, rather than a disclosed raw-material sourcing change. Management said it is working on different types of products with lower crude dependency and better margin profiles, but did not identify the inputs to be replaced, the reduction in oil-linked costs, or the expected share of sales from those products.

This distinction is material because the plan concerns the future product mix, not a near-term claim that existing categories have become less exposed. Jyothy Labs described the crude-price rise as unprecedented, and management said the development work on lower-dependency products had already been under way for quite some time before the latest call.

When will Jyothy Labs launch lower-crude products?

Jyothy Labs said it should see good products with lower crude dependency next year, but management did not give a launch calendar, product names or category details. The next-year timeframe is therefore management’s expectation from its NPD pipeline rather than formal financial guidance.

Management said the company’s launches over the last two or three years have met with reasonable success and are doing well. It contrasted that record with its hope that the next line of NPDs will also deliver, meaning prior launches have management-reported market progress while the lower-crude pipeline has not yet been tested in the market.

Jyothy Labs said it has its team, distribution channel and continuing brand-building activity in place for launches. Those capabilities were cited alongside the NPD pipeline, but management did not disclose how much it will spend on distribution, advertising or manufacturing for the products expected next year.

What has crude inflation done to Jyothy Labs margins?

Jyothy Labs said crude-price inflation affected profitability, while management said the margin impact in the Fabric Care segment was largely due to input costs. It did not quantify the profit effect, disclose a Fabric Care margin figure, or separate crude costs from other commodity inputs.

Management said margin recovery should begin in the second half, or H2, if commodity prices stabilise. That conditional view differs from a margin target: Jyothy Labs gave no H2 or FY27 margin guidance and said margins are difficult to forecast because external factors have a large influence.

For FY27, management called the year an aberration because of the external environment, geopolitical conditions and input inflation. It nevertheless said its internal aspiration is to continue delivering double-digit growth, while naming Ex, Pril and Fa as brands whose performance supports confidence in maintaining growth momentum.

How does the product pipeline support Jyothy Labs growth plans?

Jyothy Labs said NPDs will be part of its journey toward a Rs 5,000 crore revenue aim. An analyst described the company as being at roughly a Rs 3,000 crore run rate and estimated that achieving the target over three to four years would require growth of about 15% to 20%, but management did not endorse a timetable or annual growth forecast.

Management reaffirmed that Rs 5,000 crore remains its aim and said it has identified a few categories for future activity. It declined to provide category indications, saying only that investors would see such developments next year and that the products would have a better profile.

Acquisitions remain another possible growth lever, according to management, which said merger and acquisition activity is not on hold. Jyothy Labs said it is evaluating opportunities but will wait for the right fit, using a checklist intended to assess whether an acquired brand can grow profitably and has a sufficient runway.

Will Jyothy Labs use new brands and capital for new categories?

Jyothy Labs has considered building a brand in-house for new categories, M.R. Jyothy said. Management did not name the proposed categories, brand identity, launch timing or investment, so the statement establishes an organic brand-building option rather than a confirmed brand launch.

The company said not every personal-care opportunity will sit under Margo. Margo remains positioned in the natural-products space and has launched glycerine products with moringa, while management said other opportunities could be addressed through other brands or a new brand rather than through Margo extensions.

On capital allocation, an analyst cited about Rs 850 crore of cash, a buyback and potential inorganic growth. Management said the board reviews capital allocation from time to time and listed dividends, acquisitions, investment in NPDs and investment in new categories as potential uses of cash, without allocating a fixed amount to any one route.

Conclusion

Jyothy Labs is seeking to reduce future exposure to oil-linked inputs through products expected next year, after management acknowledged that crude inflation hurt profitability and an analyst put crude-linked costs at about 65% of the base. The plan also supports the Rs 5,000 crore revenue aim through NPDs, potential new categories and selective acquisitions, although management has not quantified the margin or sales contribution.

The next point to watch is whether Jyothy Labs discloses the categories, timing and cost profile of the lower-crude products expected next year. Management also tied the start of margin recovery in H2 to commodity-price stability, while its acquisition process remains unresolved because it is waiting for an opportunity that meets its stated criteria.